Results 231 to 240 of about 738,105 (258)

Oral Butyrate Reduces Progression of Kidney Damage in an L‐NAME‐Induced Diabetic Kidney Disease Mouse Model

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10278-10291, November 2026.
ABSTRACT Aims Diabetic kidney disease (DKD) is one of the main causes of kidney failure worldwide. Interestingly, patients affected by DKD are characterised by a low abundance of gut bacteria producing short fatty acids including butyrate, which is suggested to play a role in the decline of renal function.
Maria Novella Nicese, Angela Koudijs, Reshma Lalai, Cristina Avramut, Rico J. E. Derks, Elena Sánchez‐López, Martin Giera, Amanda C. M. Pronk, Artemiy Kovynev, Sander Kooijman, Patrick C. N. Rensen, Roel Bijkerk, Bernard M. van den Berg, Joris I. Rotmans   +13 more
wiley   +1 more source

Global research trends in fecal microbiota transplantation combined with immune checkpoint inhibitors for cancer immunotherapy: a bibliometric analysis. [PDF]

Transl Cancer Res
Hu Y, Hendi M, Du L, Chen X.
europepmc   +1 more source

Pronounced Reductions in Plasma Citrulline Indicate Severe Intestinal Mucosal Barrier Injury During Induction Therapy for Pediatric Acute Myeloid Leukemia

European Journal of Haematology, Volume 117, Issue 5, Page 1275-1284, November 2026.
ABSTRACT Objectives Pediatric acute myeloid leukemia (AML) chemotherapy regimens are frequently burdened by fever episodes, systemic inflammation and bloodstream infections (BSI). Mucosal barrier injury may contribute to these complications, but its role in childhood AML remains uninvestigated.
Carla Warley Kjær, Maria Ebbesen Sørum, Silvia De Pietri, Claus Moser, Malene Johanne Petersen, Marianne Hoffmann, Henrik Hasle, Sarah Weischendorff, Klaus Müller   +8 more
wiley   +1 more source

Water-responsive injectable hydrogel achieving rapid in situ gelation and long-term colonic mucoadhesion for efficient fecal microbiota transplantation. [PDF]

Bioact Mater
Chen Z, Li Y, Xiong W, Ma P, Liu W, Zhou H, Wang X, Tang Y, Cai J, Su M, Chen Z, Xiong W.   +11 more
europepmc   +1 more source

Case Report: Fecal microbiota transplantation resensitizes advanced non-small cell lung cancer to platinum-based chemotherapy. [PDF]

Front Oncol
Lee YJ, Lee JH, Cha B, Shin J, Kwon KS, Shin YW, Lee KH, Lim JH.   +7 more
europepmc   +1 more source

Validation of an Automated Fluorescence- and Image-Based Viable Cell Counting Method for Fecal Microbiota Transplantation Drug Products. [PDF]

Biotechnol J
Lang T, Farowski F, Al-Gousous J, Langguth P, Vehreschild MJGT.   +4 more
europepmc   +1 more source

Safety and efficacy of fecal microbiota transplantation in solid cancers resistant to immune checkpoint inhibitors: results of the MITRIC trial. [PDF]

J Immunother Cancer
Ullern A, Garborg KK, Chauhan SK, Holm K, Bang C, Dunn C, Johnsen PH, Hov JER, Kyte JA.   +8 more
europepmc   +1 more source

Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review of Efficacy and Safety. [PDF]

Cureus
Busmail H, Weerakoon S, Mandefro BT, Sundara SV, Lu X, Avula S, Mohammed L.   +6 more
europepmc   +1 more source

Concomitant medication reporting should accompany fecal microbiota transplantation plus anti-PD-1 therapy in gastric cancer. [PDF]

J Immunother Cancer
Mao G, Lan H.
europepmc   +1 more source